Objectives: Dextrose prolotherapy is one of the most promising minimally invasive interventions for temporomandibular disorder (TMD), particularly in refractory cases where other conservative treatments have failed. The purpose of this study was to demonstrate the efficacy of a new treatment, temporomandibular joint (TMJ) prolotherapy, in patients with TMD to alleviate symptoms.
Materials And Methods: A retrospective analysis was conducted on TMD patients with chronic pain who did not respond to conventional treatments. TMJ prolotherapy was performed using hypertonic dextrose in the TMJ area, targeting the retrodiscal attachment tissue, anterior disc attachment tissue, lateral capsule, origin of the masseter muscle, and the stylomandibular ligament. Pain or discomfort intensity in the TMJ was evaluated using a numerical rating scale (NRS). Maximum mouth opening and subjective satisfaction were also analyzed.
Results: Nineteen patients (6 males, 13 females, average age 43 years) participated in this study. All patients experienced pain improvement with a maximum of three prolotherapy sessions. The initial mean NRS was 5.7, which ultimately decreased to a final mean TMJ discomfort score of 1.7 postintervention. The patients' maximum mouth opening increased from an initial 34.5 mm to 38.8 mm, and they reported positive satisfaction with the prolotherapy treatment. The clinical outcomes were positive regardless of main origin of TMD symptoms.
Conclusion: Hypertonic TMJ prolotherapy is an effective minimally invasive intervention for TMJ disorders with chronic pain.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535124 | PMC |
| http://dx.doi.org/10.5125/jkaoms.2024.50.5.259 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Efficacy of dextrose prolotherapy on temporomandibular disorder: a retrospective study.
J Korean Assoc Oral Maxillofac Surg
October 2024
Department of Oral and Maxillofacial Surgery, Section of Dentistry, Seoul National University Bundang Hospital, Seongnam, Korea.
Objectives: Dextrose prolotherapy is one of the most promising minimally invasive interventions for temporomandibular disorder (TMD), particularly in refractory cases where other conservative treatments have failed. The purpose of this study was to demonstrate the efficacy of a new treatment, temporomandibular joint (TMJ) prolotherapy, in patients with TMD to alleviate symptoms.
Materials And Methods: A retrospective analysis was conducted on TMD patients with chronic pain who did not respond to conventional treatments.
Efficacy of dextrose prolotherapy for temporomandibular joint hypermobility: A systematic review and meta-analysis.
Cranio
October 2024
Department of Stomatology, Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang, China.
Objective: We reviewed the efficacy of dextrose prolotherapy versus placebo and other active interventions, like autologous blood injection (ABI) and botulinum toxin (BTX), in improving the outcomes of temporomandibular joint (TMJ) hypermobility.
Methods: We searched PubMed, the Cochrane CENTRAL library, Embase, Scopus, and Web of Science databases to identify randomized controlled trials (RCTs) . Maximal mouth opening (MMO), pain, and frequency of dislocations were analyzed.
Evaluation of Efficacy of 10% Dextrose Prolotherapy in Management of Temporomandibular Joint Disorders: A Prospective Study.
Indian J Otolaryngol Head Neck Surg
October 2024
Department of Dentistry, Autonomous State Medical College, Kaushambi, Uttar Pradesh India.
Article Synopsis
- The study investigated the effectiveness of 10% dextrose prolotherapy for treating temporomandibular joint disorders (TMDs) in 30 patients who had symptoms for over six months and didn't respond to other treatments.
- The treatment involved four injection sessions over three months, with assessments made on pain, joint locking, and mouth opening at each visit.
- Results showed significant improvement in TMD symptoms, suggesting that dextrose prolotherapy could be a viable alternative to long-term medications or surgery.
Evaluation of the effect of dextrose prolotherapy versus deep dry needling therapy for the treatment of temporomandibular joint anterior disc displacement with reduction: (a randomized controlled trial).
Clin Oral Investig
August 2024
Department of Oral and Maxillofacial Surgery, Faculty of Dental Medicine, Beni-Suef University, East Nile educational compound, Beni-Suef, 62764, Egypt.
Objective: to compare the combined effect of Prolotherapy and Deep Dry Needling (DDN) versus DDN effect on relieving the symptoms of Temporomandibular joint (TMJ) anterior disc displacement.
Patients And Methods: The clinical trial randomly allocated forty patients. The (control group) patients received four intraarticular and masseteric DDN sessions, while the (study group) patients were subjected to the exact technique followed by Prolosolution injection.
Comparison of Autologous Blood Injection and Dextrose Prolotherapy in the Treatment of Chronic Recurrent Temporomandibular Dislocation: A Randomized Clinical Trial.
J Maxillofac Oral Surg
April 2024
Department of Oral and Maxillofacial Surgery, Government Dental College and Hospital, Mumbai, India.
Introduction: Prolotherapy is a minimally invasive technique that aims to functionally restore or repair the soft and hard tissues of the TMJ by injecting a stimulant. The present study was conducted to compare the effectiveness of dextrose and autologous blood injection (ABI) as prolotherapy agents in the treatment of patients with chronic recurrent TMJ dislocation (CRTD).
Materials And Method: Thirty-two patients were divided into two groups-ABI and dextrose ( = 16 each).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!